Receptor‐interacting protein 140 overexpression impairs cardiac mitochondrial function and accelerates the transition to heart failure in chronically infarcted rats

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Translational research : the journal of laboratory and clinical medicine

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.trsl.2016.08.005PMID 27639592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RIP140 Represses the “Brown-in-White” Adipocyte Program Including a Futile Cycle of Triacyclglycerol Breakdown and Synthesis

  2014cited by this paper
• Simulated microgravity‐induced mitochondrial dysfunction in rat cerebral arteries

  2014cited by this paper
• The p65 subunit of NF-κB involves in RIP140-mediated inflammatory and metabolic dysregulation in cardiomyocytes.

  2014cited by this paper
• Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats

  2013cited by this paper
• Mitochondria as a therapeutic target in heart failure.

  2013cited by this paper
• Distinct functions for RIP140 in development, inflammation, and metabolism.

  2013cited by this paper
• Absence of RIP140 Reveals a Pathway Regulating glut4-Dependent Glucose Uptake in Oxidative Skeletal Muscle through UCP1-Mediated Activation of AMPK

  2012cited by this paper
• Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes.

  2012influential reference
• NF-κB-mediated degradation of the co-activator RIP140 regulates inflammatory response and contributes to endotoxin tolerance

  2012cited by this paper
• Targeting myocardial substrate metabolism in heart failure: potential for new therapies

  2012cited by this paper
• Prospects for gene transfer for clinical heart failure

  2012cited by this paper
• Evaluation of Mitochondrial Toxicity in Marmota himalayana Treated with Metacavir, a Novel 2′,3′-Dideoxyguanosine Prodrug for Treatment of Hepatitis B Virus

  2011cited by this paper
• PGC-1&bgr; Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy

  2011cited by this paper
• Peroxisome Proliferator-Activated Receptor &bgr;/&dgr; Activation in Adult Hearts Facilitates Mitochondrial Function and Cardiac Performance Under Pressure-Overload Condition

  2011cited by this paper
• Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice

  2011cited by this paper
• Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

  2010influential reference
• Defective DNA Replication Impairs Mitochondrial Biogenesis In Human Failing Hearts

  2010cited by this paper
• PGC-1 Coactivators in Cardiac Development and Disease

  2010cited by this paper
• Mitochondria in heart failure.

  2010influential reference
• Increased Expression of Integrin-Linked Kinase Attenuates Left Ventricular Remodeling and Improves Cardiac Function After Myocardial Infarction

  2009cited by this paper
• Impaired energetics in heart failure - a new therapeutic target.

  2008cited by this paper
• Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart.

  2008cited by this paper
• Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis.

  2008cited by this paper
• Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation

  2008cited by this paper
• Coactivator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression.

  2008cited by this paper
• The Transcriptional Corepressor RIP140 Regulates Oxidative Metabolism in Skeletal Muscle

  2007cited by this paper
• Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart Failure

  2006cited by this paper
• Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice

  2006cited by this paper
• Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice

  2006cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Mitochondrial energy metabolism in heart failure: a question of balance.

  2005cited by this paper
• Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity

  2005cited by this paper
• Nuclear receptor signaling and cardiac energetics.

  2004cited by this paper
• Glucose transport in the heart.

  2004cited by this paper
• Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner

  2004cited by this paper
• Glucose transport in the heart

  2004cited by this paper
• Peroxisome Proliferator-Activated Receptors and Atherogenesis: Regulators of Gene Expression in Vascular Cells Nuclear Receptor Signaling in the Control of Cholesterol Homeostasis: Have the Orphans Found a Home? Nuclear Receptor Signaling and Cardiac Energetics

  2004cited by this paper
• Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia.

  2003cited by this paper
• Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

  2001cited by this paper
• Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

  2000cited by this paper
• Prospects for gene therapy for heart failure.

  2000influential reference
• Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy

  1999influential reference
• Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.

  1997cited by this paper
• Dichloroacetate as metabolic therapy for myocardial ischemia and failure.

  1997cited by this paper
• Efficient gene transfer into myocardium by direct injection of adenovirus vectors.

  1993cited by this paper

• SIRT5 prevents mitochondrial dysfunction and cardiac hypertrophy induced by RIP140

  2025cites this paper
• Down syndrome is an oxidative phosphorylation disorder

  2021cites this paper
• Mitochondrial transplantation as a potential and novel master key for treatment of various incurable diseases

  2019cites this paper
• SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.

  2019cites this paper